Nanxi Li

Statistics

Publications

Citations

296

H-Index

Active since

2022

Affiliations

Hong Kong Baptist University(Current)

Southern University of Science and Technology

Air Force Medical University

Chinese University of Hong Kong

Peking Union Medical College Hospital

Nanxi Li is an author at Hong Kong Baptist University specializing in postmenopausal osteoporosis treatment, bone resorption inhibition, and osteoporosis.

ORCID

Publications per year

2022–2024

Publications

Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation

Yuanyuan Yu, Luyao Wang, Shuaijian Ni et al. · Nature Communications · 2022 · 189 citations · Full text

Medicine, Cardiology, Pharmacology +14

Therapeutic aptamer targeting sclerostin loop3 for promoting bone formation without increasing cardiovascular risk in osteogenesis imperfecta mice

Luyao Wang, Yuanyuan Yu, Shuaijian Ni et al. · Theranostics · 2022 · 90 citations · Full text

Medicine, Immunology, Pharmacology +15

Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity

Chuanxin Zhong, Nanxi Li, Shengzheng Wang et al. · Nature Communications · 2024 · 17 citations · Full text

Medicine, Endocrinology, Pharmacology +17

1–3 of 3